NCT02749903 2026-02-11Enzalutamide for Patients With Androgen Receptor Positive Salivary CancersAlliance for Clinical Trials in OncologyPhase 2 Active not recruiting46 enrolled 11 charts
NCT04052204 2021-10-14Avelumab With Bempegaldesleukin With or Without Talazoparib or Enzalutamide in Advanced or Metastatic Solid TumorsPfizerPhase 1/2 Terminated3 enrolled 12 charts